MedPath

Vitamin K injection protection by muscular vs venous delivery in preterm infants

Phase 2
Conditions
Health Condition 1: P073- Preterm [premature] newborn [other]
Registration Number
CTRI/2024/03/064903
Lead Sponsor
Divya A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Preterm infants between 28 0/7 weeks to 33 6/7 weeks

Exclusion Criteria

Fetal intracranial Hemorrhage

History of Alloimmune Thrombocytopenia

Maternal antiplatelet antibodies

Major Congenital abnormalities such as congential diaphragmatic hernia, anorectal malformation, VACTERL association, intestinal atresia

Bruised at Birth

Large Subgaleal bleed

Mother on treatment with vitamin k antagonist, Heparin, warfarin

APGAR BELOW 3 at 1 minute of life

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath